Instead, prednisone treatment initiated in patients with early suspicion of pulmonary fibrosis (both from the group on dexamethasone treatment and from the group that did not receive dexamethasone) was correlated with the reduction of fibrosis biomarkers and specific genes (matrix metalloproteinase 8 [MMP8], phosphodiesterase 4D [PDE4D], cysteine-rich secretory protein [CRISP3], B-cell lymphoma 2 like protein 15 [BCL2L15] that were previously upregulated towards those observed in non-pulmonary fibrosis group [124]. The gene discussed is BCL2L15; the disease is pulmonary fibrosis.